A Study of Omaveloxolone in Children With Friedreich's Ataxia
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
This is an open-label study evaluating the safety, tolerability, and PK following single-dose
administration of omaveloxolone in pediatric patients with FA. The study will consist of 3
parts (Parts A, B, and C) based on age.